Novo Nordisk A/S (NVO)

59.84
0.53 0.89
NYSE : Health Technology
Prev Close 59.31
Open 59.59
Day Low/High 59.25 / 60.39
52 Wk Low/High 46.47 / 64.82
Volume 1.90M
Avg Volume 1.94M
Exchange NYSE
Shares Outstanding 1.86B
Market Cap 145.73B
EPS 2.50
Div & Yield 0.88 (1.46%)
For Those More Sanguine Than I

For Those More Sanguine Than I

Investors without a deep-value bias might want to consider these.

FDA Won't Approve Novo Nordisk Insulin: Hot Trends

FDA Won't Approve Novo Nordisk Insulin: Hot Trends

U.S. regulators say they will not approve Novo Nordisk's new long-acting insulin Tresiba until more testing of it is conducted.

Rules of the Game: Healthcare Stocks Show Big Potential

Rules of the Game: Healthcare Stocks Show Big Potential

This sector is outperforming, and these two names are compelling on a pullback.

Rules of the Game: Further on Free Cash Flow

Rules of the Game: Further on Free Cash Flow

This metric is a prime indicator of financial health, and these health-related stock stand out.

5 Dumbest Things on Wall Street: Jan. 20

5 Dumbest Things on Wall Street: Jan. 20

Here is this week's roundup of the dumbest actions on Wall Street.

A Prescription for Growth

A Prescription for Growth

In the large, but targeted, market for diabetes drugs, two very different companies share a deeper commitment.

Finding an Antidote for Health Care

The sector is in the doldrums, yet the prospects for these three names are quite strong.